US2010240724A1PendingUtilityA1

Edible Film

30
Assignee: C L PHARMPriority: Oct 3, 2007Filed: Sep 25, 2008Published: Sep 23, 2010
Est. expiryOct 3, 2027(~1.2 yrs left)· nominal 20-yr term from priority
A61P 31/12A61P 5/00A61P 35/00A61P 25/00A61P 3/00A61P 29/00A61P 21/00A61P 15/00A61P 19/00A61P 1/00A61K 9/7007A61K 31/4184A61K 9/0056A23P 20/20A61K 9/006A23L 33/10A61K 31/4045A23L 29/20A23L 29/206
30
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to an edible film composition comprising a waxy starch hydrolysate, a modified starch and a water-soluble polymer, and an edible film comprising the same. The present edible film may not only have an excellent film forming property, solubility and feeling in the oral cavity, but also be easily prepared at low cost, and thus be usefully used as an oral cleanser or a bad breath remover for oral cleansing, and a soluble formulation on tongue for uptake of drug in the oral cavity.

Claims

exact text as granted — not AI-modified
1 - 11 . (canceled) 
     
     
         12 . An edible film made by an edible film composition which comprises a waxy starch hydrolysate, a modified starch and a water-soluble polymer. 
     
     
         13 . The edible film according to  claim 12 ,
 wherein the waxy starch hydrolysate is a hydrolysate from a waxy starch comprising 80% or more of amylopectin.   
     
     
         14 . The edible film according to  claim 12 ,
 wherein the waxy starch is a starch derived from one or more plants selected from the group consisting of rice, wheat, sweet potato, potato, corn and tapioca.   
     
     
         15 . The edible film according to  claim 12 ,
 wherein the waxy starch hydrolysate is formed by treating a waxy starch with an acid or an enzyme.   
     
     
         16 . The edible film according to  claim 12 ,
 wherein the waxy starch hydrolysate is formed by treating the oxidized, etherified or esterified starch with an acid or an enzyme or by oxydizing, etherifying or esterifying an acid- or enzyme-treated waxy starch.   
     
     
         17 . (canceled) 
     
     
         18 . The edible film according to  claim 15 ,
 wherein the enzyme treatment is carried out by one or more enzymes selected from the group consisting of alpha amylase, heat resistant alpha amylase, pullulanase, isoamylase, glucoamylase and beta amylase.   
     
     
         19 . The edible film according to  claim 12 ,
 wherein the waxy starch hydrolysate has a viscosity, in 20% solution at 40° C., of 500 to 5,000 cps.   
     
     
         20 . The edible film according to  claim 12 ,
 wherein the modified starch is modified from a starch by one or more reactions selected from the group consisting of oxidation, esterification, etherification, cross-linking reaction, and pregelatinization.   
     
     
         21 . The edible film according to  claim 12 ,
 wherein the modified starch is one or more starches selected from the group consisting of oxidized starch, acetylated distarch adipate, acetylated distarch phosphate, starch sodium octenyl succinate, low viscosity starch octenyl succinate, octenyl distarch phosphate, monostarch phosphate, phosphated distarch phosphate, starch acetate, hydroxyethyl starch, oxidized starch acetate, hydroxypropyl distarch phosphate and hydroxypropyl starch.   
     
     
         22 . (canceled) 
     
     
         23 . The edible film according to  claim 12 ,
 wherein the modified starch is a modified starch comprising less than 50% amylose.   
     
     
         24 . (canceled) 
     
     
         25 . The edible film according to  claim 12 ,
 wherein the water-soluble polymer is one or more water-soluble polymers selected from the group consisting of pullulan, gelatin, pectin, low viscosity pectin, hydroxypropylmethyl cellulose, low viscosity hydroxypropylmethyl cellulose, alginic acid, low viscosity alginic acid, sodium alginate, carrageenan, arabic gum, guar gum, locust bean gum, xanthan gum, gellan gum and agar.   
     
     
         26 . The edible film according to  claim 12 ,
 wherein the water-soluble polymer is one or more water-soluble polymers selected from the roup consisting of pullulan, gelatin, pectin, low viscosity pectin, low viscosity alginic acid, hydroxypropylmethyl cellulose and low viscosity hydroxypropylmethyl cellulose.   
     
     
         27 . (canceled) 
     
     
         28 . The edible film according to  claim 12 ,
 comprising 10 to 50 parts by weight of the waxy starch hydrolysate, 10 to 50 parts by weight of the modified starch and 10 to 70 parts by weight of the water-soluble polymer.   
     
     
         29 . The edible film according to  claim 12 ,
 further comprising one or more additives selected from the group consisting of a filler, a plasticizer, a sweetener, an acidulant, a flavoring, an emulsifier, a bad breath remover, a color and a refrigerant.   
     
     
         30 - 37 . (canceled) 
     
     
         38 . The edible film according to  claim 12 ,
 wherein the edible film has a thickness of 20 μm to 100 μm.   
     
     
         39 . A soluble formulation on tongue comprising a waxy starch hydrolysate, a modified starch, a water-soluble polymer and a pharmaceutically active ingredient. 
     
     
         40 . The soluble formulation on tongue according to  claim 39 , wherein the pharmaceutically active ingredient is one or more ingredients selected from the group consisting of antidiabetics; insomnia therapeutics; urogenital therapeutics; obesity therapeutics; enzymes; anti-peptic ulcer agents; antitussives/expectorants; skin disorder therapeutics; antiemetics; antidepressants; antihistamines; antipyretic analgesics/anti-immflammatory agents; hormones; circulatory therapeutics; digestive organ therapeutics; psychoneurosis therapeutics; impotence therapeutics; osteoporosis therapeutics; arthritis therapeutics; epilepsy therapeutics; muscle relaxants; brain function improvers; schizophrenia therapeutics; immunosuppressants; antibiotics; anticancer drugs; anticancer therapeutic supplements; vaccines; oral cleansers; antianemics; constipation therapeutics; vitamins; nutrients; lactobacillus formulations; anti-common-cold drug complexes; or health care foods. 
     
     
         41 . The soluble formulation on tongue according to  claim 39 , wherein the pharmaceutically active ingredient is one or more components selected from the group consisting of triclosan, cetyl pyridiumchloride, domiphen bromide, quarternary ammonium salts, zinc compounds, sanguinarine, fluorides, alexidine, octonidine, EDTA, aspirin, acetaminophen, ibuprofen, ketoprofen, diflunisal, fenoprofen calcium, naproxen, tolmetin sodium, indomethacin, benzonatate, caramiphen, edisylate, menthol, dextromethrophan, hydrobromides, hydrochlorides, chlophedianol, diphenhydramine, pseudoephedrine, phenylepherine, phenylpropanolamine, pseudoephedrine sulfate, brompheniramine maleate, chlorpheniramine maleate, carbinoxamine maleate, clemastine fumarate, dexchlorpheniramine maleate, diphenhydramine hydrochloride, diphenhydramine citrate, diphenylpyraline hydrochloride, doxylamine succinate, promethazine hydrochloride, pyrilamine maleate, tripelenamine citrate, triprolidine hydrochloride, acrivastine, loratadine, brompheniramine, dexbrompheniramine, guaifenesin, ipecac, calcium iodide, terpin hydrate, loperamide, famotidine, ranitidine, omeprazole, lansoprazole, aliphatic alcohols, nicotine, caffeine, strychnine, picrotoxin, pentylenetetrazol, phenyhydantoin, phenobarbital, primidone, carbamazepine, ethosuximide, methsuximide, phensuximide, trimethadione, diazepam, benzodiazepine, phenacemide, pheneturide, acetazolamide, sulthiame, bromides, levodopa, amantadine, morphine, heroin, hydromorphone, metopon, oxymorphone, levorphanol, codeine, hydrocodone, xycodone, nalorphine, naloxone, naltrexone, salycilates, phenylbutazone, indomethacin, phenacetin, chlorpromazine, methotrimeprazine, haloperidol, clozapine, reserpine, imipramine, tranylcypromine, phenelzine, lithium, apomorphine, sildenafil, tadalafil, vardenafil, zolpidem tartrate, bambuterol hydrochloride, galantamine chlorobromide, nicardipine hydrochloride, paroxetine hydrochloride, meloxicam, tolteridine tartrate and doxazosin mesylate. 
     
     
         42 . A process for preparing an edible film comprising:
 (1) preparing an edible film composition comprising a waxy starch hydrolysate, a modified starch and a water-soluble polymer;   (2) pouring the edible film composition into a molding machine to mold it into a film at 50 to 80° C.;   (3) maturing the molded film at a relative humidity of 50 to 70% for 1 to 10 days.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.